These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 124527)

  • 1. Plasma levels of nicotinic acid compounds in niceritrol-treated rabbits.
    Brattsand R; Harthon L
    Acta Pharmacol Toxicol (Copenh); 1975 Mar; 36(3):203-14. PubMed ID: 124527
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of niceritrol (pentaerythritoltetranicotinate) and clofibrate upon hyperlipemia and atherosclerosis induced in rabbits by cholesterol-free semisynthetic diets.
    Brattsand R
    Atherosclerosis; 1974; 20(3):453-67. PubMed ID: 4373017
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of niceritrol (pentaerythritoltetranicotinate) on experimental atherosclerosis in cholesterol-fed rabbits at different levels of plasma cholesterol.
    Brattsand R
    Acta Pharmacol Toxicol (Copenh); 1975 Jan; 36(1):39-55. PubMed ID: 1173722
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute effects on plasma lipids in the rat of a new long-acting nicotinic acid derivative: LG 13979.
    Subissi A; Criscuoli M; Biagi M; Murmann W
    J Pharm Pharmacol; 1983 Sep; 35(9):571-5. PubMed ID: 6138406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subacute administration of pentaerythritoltetranicotinate (Perycit) to man.
    Harthon L; Svedmyr N
    Atherosclerosis; 1974; 20(1):65-8. PubMed ID: 4617581
    [No Abstract]   [Full Text] [Related]  

  • 6. A nicotinic acid ester and experimental atherosclerosis: no significant effect of treatment with niceritrol (pentaerythritoltetranicotinate) on cholesterol in aorta of rabbits previously fed with cholesterol-enriched diet.
    Stender S; Astrup P; Brattsand R
    Atherosclerosis; 1976; 23(3):503-11. PubMed ID: 1267865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Action of niceritrol (pentaerythritoltetranicotinate) on lipid accumulation in aortas of cholesterol-fed rabbits independent of contemporary reduction of serum lipids.
    Brattsand R; Petersen H; Lundholm L
    Atherosclerosis; 1974; 20(3):469-79. PubMed ID: 4373018
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship of nicotinamide and nicotinic acid to hypolipidemia.
    Dalton C; VanTrabert TC; Dwyer JX
    Biochem Pharmacol; 1970 Sep; 19(9):2609-19. PubMed ID: 4249087
    [No Abstract]   [Full Text] [Related]  

  • 9. Dose-response effect of single and combined clofibrate (Atromidin) and niceritrol (Perycit) treatment on serum lipids and lipoproteins in type II hyperlipoproteinaemia.
    Olsson AG; Orö L; Rössner S
    Atherosclerosis; 1975; 22(1):91-101. PubMed ID: 1098680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some cardiovascular effects of LG 13979: comparison with nicotinic acid and other nicotinic acid derivatives.
    Subissi A; Bachi M; Brunori P
    J Pharm Pharmacol; 1983 Sep; 35(9):612-4. PubMed ID: 6138419
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of plasma levels of free nicotinic acid in rats and rabbits treated with nicotinic acid, pentaerythritol tetranicotinate (Perycit) and 2,6-pyridine dimethanol dinicotinoate.
    Testa R; Gambini M; Canestrini C
    Farmaco Prat; 1978 Nov; 33(11):463-71. PubMed ID: 750231
    [No Abstract]   [Full Text] [Related]  

  • 12. Actions of vitamins A and E and some nicotinic acid derivatives on plasma lipids and on lipid infiltration of aorta in cholesterol-fed rabbits.
    Brattsand R
    Atherosclerosis; 1975; 22(1):47-61. PubMed ID: 1156470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of nicotinic acid, niceritrol and beta-pyridylcarbinol on experimental hyperlipidemia and atherosclerosis in mini-pigs.
    Lundholm L; Jacobsson L; Brattsand R; Magnusson O
    Atherosclerosis; 1978 Feb; 29(2):217-39. PubMed ID: 646851
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in the fatty acid composition of the plasma lipid esters during lipid-lowering treatment with diet, clofibrate and niceritrol. Reduction of the proportion of linoleate by clofibrate but not by niceritrol.
    Vessby B; Lithell H; Gustafsson IB; Boberg J
    Atherosclerosis; 1980 Jan; 35(1):51-65. PubMed ID: 6989377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of some pharmacological properties and side effects of D-glucitol hexanicotinate (sorbinicate) and nicotinic acid correlated with the plasma concentration of nicotinic acid.
    Subissi A; Schiantarelli P; Biagi M; Sardelli G
    Atherosclerosis; 1980 May; 36(1):135-48. PubMed ID: 7387773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Niacin and niacinamide transport in the central nervous system. In vivo studies.
    Spector R
    J Neurochem; 1979 Oct; 33(4):895-904. PubMed ID: 158635
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of niceritrol on lipid metabolism of aorta in atherosclerotic rats.
    Shirai K; Ishikawa Y; Nishide T; Sasaki N; Murano S; Sato A; Matsuoka N; Saito Y; Yoshida S
    Tohoku J Exp Med; 1984 Jun; 143(2):231-8. PubMed ID: 6474452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the absorption, excretion and metabolism of pentaerythritoltetranicotinate.
    Harthon L; Sigroth K
    Arzneimittelforschung; 1974 Oct; 24(10):1688-92. PubMed ID: 4373013
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics and hypolipidemic activity of clofibrate-nicotinic acid combinations in rats.
    Cayen MN; Robinson WT; Dubuc J; Dvornik D
    Biochem Pharmacol; 1979 Apr; 28(7):1163-7. PubMed ID: 444274
    [No Abstract]   [Full Text] [Related]  

  • 20. Absorption and excretion of radioactive pentaerythritoltetranicotinate, mesoinositolhexanicotinate and nicotinic acid after oral administration to cat.
    Brattsand R; Harthon L
    Arzneimittelforschung; 1971 Sep; 21(9):1335-8. PubMed ID: 5171788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.